Current Research on Therapy in Alzheimer’s Disease Experimental Model: Beta-Amyloid1-42 Induction
DOI:
https://doi.org/10.53555/nnpbs.v1i10.562Keywords:
Alzheimer’s disease, β-amyloid1-42, treatment, hippocampusAbstract
Alzheimer’s disease (AD) is a neurodegenerative disorder commonly associated with brain ?-amyloid accumulation (A?). Early in disease, individuals have impairment in short-term memory, but keeps alert preserved sensory and motor functions, progressing to cognitive functions total loss. The aim of this study is to present main substances currently investigated in Alzheimer’s disease experimental model induced by A?1-42 and its possible therapeutic actions. For this, we realized an exhaustive literature research, and main results data compiled and analyzed. Thus, there were observed three agents’ classes used to treat AD: antioxidants, anti-inflammatory, and calcium homeostasis regulators, with 15 substances found. In conclusion, it can be seen that these agents have beneficial results which suggest actions that may be used in clinical practice to pathology treatment.
References
Selkoe D. J. Alzheimer’s Disease: Genes, Proteins, and Therapy. Physiological Reviews 81, 2, (2001)
Bombois S, Duhamel A, Salleron J, Deramecourt V, Mackowiak M-A, Deken V. A New decision tree combining abeta 1-42 and p-tau levels in Alzheimer’s Disease. Current Alzheimer Research 10, 357-364, (2013)
Querfurth H. W, Laferla F. M. Mechanism of disease Alzheimer’s Disease. The New England Journal of Medicine 362, 329-344, (2010)
Reitz C, Mayeux R. Alzheimer’s disease: Epidemiology, diagnostic criteria, risk factors and biomarkers. Biochemical Pharmacology 88, 640-651, (2014)
Abramov E. et al. Amyloid-B as a positive endogenous regulator of release probability at hippocampal synapses. Nature Neurosciece 12, 12, 1567-1576, (2009)
Selkoe J. D. The therapeutics of Alzheimer’s Disease: Where we stand and where we are heading. Ann Neurol 73, 328-336, (2013)
Hardy, J.; Selkoe, D.J. The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science 297(5580), 353-356. (2002)
Benedikz E, Kloskovwka E, Winblad B. The rat as model of Alzheimer’s Disease. J Cell. Mol. Med 13, 6, (2009)
Belarbi K, Burnouf S, Fernandez-Gomez F, Laurent C, Lestavel S, Figeac M, et al. Beneficial effects of exercise in a trangenic mouse modelo f Alzheimer’s disease-like Tau pathology. Neurobiology of disease 43, 486-494, (2011)
Cetin F, Dincer S. The effect of intrahippocampal beta amyloid (1-42) peptide injection on oxidant and antioxidante status in rat brain. Ann. N. Y. Acad. Sci. 1100, 510-517, (2007)
Messier C, Émond S, Ethier K. New techniques in stereotaxic surgery and anestesia in the mouse. Pharmacology Biochemistry and Behavior 63, 2, 313-318, (1999)
Moghaddam A. H, Hosseini R. S, Roohbakhsh A. Anxiogenic effect of CCK8s in the ventral hippocampus of rats: possible involvement of GABAA receptors. Pharmacological Reports 64, 45-53. (2012)
Green C. J, Knight J, Precious S, Simpkin S. Ketamine alone and combined with diazepam or xylazine in laboratory animals: a 10 year experience. Laboratory Animals 15, 163-170, (1981)
Welberg L. A. M, Kinkead B, Thrivikraman K. V, Huerkamp M. J, Nemeroff C. B, Plotsky P. M. Ketamine-Xylazine-Acepromazine Anesthesia and Postoperative Recovery in Rats. Journal of the American Association for Laboratory animal Science 45, 2, 13-20, (2006)
Reagan-Shaw S, Nihal M, Ahmad N. Dose translation from animal to human studies revisited. The FASEB Journal 22, 659-661, (2007)
Paxinos G, Watson C, Pennisi M, Topple Ann. Bregma, lambda and the interaural midpoint in stereotaxic surgery with rats of different sex, strain and weight. Journal of Neuroscience Methods 13, 139-143, (1985)
Cetin A, Komai S, Eliava M, Seeburg P. H, Osten P. Stereotaxic gene delivery in the rodent brain. Nature Protocols 1, 6, 3166-3173, (2006)
Cummings J. L, Morstorf T, Zhong K. Alzheimer’s disease drug-development pipeline: few candidates, frequente failures. Alzheimer’s Research & Therapy 6, 1-7, (2014)
Hyde C, Peters J, Bond M, Rogers G, Hoyle M, Anderson R. et al. Evolution of the evidence on the effectiveness and cost-effectiveness of acetylcholinesterase inhibitors and memantine for Alzheimer’s disease systematic review and economic model. Age and Ageing 42, 14-20, (2013)
Mattson M. P. Pathways Towards and Away from Alzheimer’s Disease. Nature 430, 631-639, (2004)
Jones D. P. Redefining Oxidative Stress. Antioxidants & Redox Signaling, 8, 9, 1865-1879, (2006)
Mariani E, Polidori M. C, Cherubini A, Mecocci P. Oxidative stress in brain aging, neurodegenerative and vascular diseases: An overview. Journal of Chromatography B 827, 65-75, (2005)
Albani D, Polito L, Forloni G. Sirtuins as novel target for Alzheimer’s disease and other neurodegenerative disorders: experimental and genetic evidence. Journal Alzhimer’s Disease 19, 1, 11-26, (2010)
Yan L, Liu N, Wang Y, Machida H, Qi X. Production of 5-hydroxymethylfurfural from corn stalk catalized by corn stalk-derived carbonaceous solid acid catalyst. Bioresource Technology 173, 462-466, (2014)
Festoff B. W, Ameenuddin S, Arnold P. M, Wong A, Santacruz K. S, Citron B. A. Minocycline neuroprotects, reduces microgliosis, and inhibits caspase protease expression. Early after spinal cord injury. J Neurochem 97, 5, 1314-1326, (2006)
Ryu J. K, McLarnon J. G. Minocycline or iNOS inhibition block 3-nitrotyrosine increases and blood-brain barrier leakiness in amyloid beta-peptide-injected rat hippocampus. Experimental Neurology 198, 2, 552-557, (2006)
Kim S-K, Rajapakse N. Enzymatic production and biological activities of chitosan oligosaccharides (COS): A review. Carbohydrate Polymers 62, 4, 357-368, (2005)
Khattab R, Eskin M, Aliani M, Thiyam U. Determination of Sinapic Acid Derivatives in Canola Extracts Using High-Performance Liquid Chromatography. J Am Oil Chem Soc 87, 147-155, (2010)
Wang S, Yu Y, Feng Y, Zou F, Zhang X, Huang J. et al. Protective effect of the orientin on noiseinduced cognitive impairments in mice. Behavioural Brain Research 296, 290-300, (2016)
Ding X, Saxena N. K, Lin S, Gupta N, Anania F. A. Exendin-4, a Glucagon-like Protein-1 (GLP1) Receptor agonist, reverses hepatic steatosis in ob/ob mice. Hepatology 43, 1, 173-181, (2006)
Wallace T. C. Anthocyanins in Cardiovascular Disease. Advances in Nutrition 2, 1, 1-7, (2011)
Badshah H, Kim T. H, Kim M. O. Protective effects of Anthocyanins against Amyloid betainduced neurotoxicity in vivo and in vitro. Neurochemistry International 80, 51-59, (2015)
Rogers J, Webster S, Lue L, Brachova L, Civin W. H, Emmerling M et al. Inflammation and Alzheimer’s disease Pathogenesis. Neurobiology of Aging, 17, 5, 681-686, (1996)
Akiyama H, Barger S, Barnum S, Bradt B, Bauer J, Cole G. M. et al. Inflammation and alzheimer’s disease. Neurobiology of Aging, 21, 383-421, (2000)
Block M. L, Hong J. Microglia and inflammation-mediated neurodegeneration: Multiple trigger with a common mechanism. Progress in Neurobiology 76, 2, 77-98, (2005)
Sastre M, Klockgether T, Heneka M. T. Contribuition of inflammatory processes to Alzheimer’s disease: molecular mechanisms. International Journal of Developmental Neuroscience 24, 167- 176, (2006)
Heneka M. T, O’Banion M. K. Inflammatory processes in Alzheimer’s disease. Journal of Neuroimmunology 184, 69-91, (2007)
Tuppo E, Arias H. R. The role of inflammation in Alzheimer’s disease. The International Journal of Biochemistry & Cell Biology 37, 289-305, (2005)
He F-J, Chen J-Q. Consumptiom of soybean, soy foods, soy isoflavones and breast câncer incidence: Differences between Chinese women and women in Western countries and possible mechanisms. Food Science and Human Wellness 2, 3-4, 146-161, (2013)
Yu X, Wang L-n, Ma L, You R, Cui R, Ji D. et al. Akebia saponin D attenuates ibotenic acidinduced cognitive déficits and pro-apoptotic response in rats: Involvement of MAPK signal pathway. Pharmacology Biochemistry and Behavior 10, 3, 479-486, (2012)
Hou Z, Luo W, Sun X, Hao S, Zhang Y, Xu F. et al. k. Brain Research Bulletin 88, 6, 560-565, (2012)
Wang C, Li J, Liu Q, Yang R, Zhang H, Cao Y, et al. Hydrogen-rich saline reduces oxidative stress and inflammatory by inhibit of JNK and NF-kB activation in a rat model of amyloid-betainduced Alzheimer’s disease. Neuroscience Letters 491, 2, 127-132, (2011)
Li N, Zhou L, Li W, Liu Y, Wang J, He P. Protective effects of ginsenosides Rg1 and Rb1 on an Alzheimer’s disease mouse model: A metabolomics study. Journal of Chromatography B 985, 54- 61, (2015)
Wang Y, Liu J, Zhang Z, Bi P, Qi Z, Zhang C. Anti-neuroinflammatory effect of ginsenoside Rbl in a rat model of Alzheimer disease. Neuroscience Letters 487, 1, 70-72, (2011)
Cai X-H, Wang S, Chen B-A. Research advances on the Pharmacological effects of Tetrandine. Chinese journal of natural Medicines 9, 6, 473-480, (2011)
Shouk R, Abdou A, Shetty K, Sarkar D, Eid A. H. Mechanisms underlying the antihypertensive effects of garlic bioactives. Nutrition Research 34, 2, 106-115, (2014)
Islamian J. P, Mehrali H. Lycopene as a carotenoid provides radioprotectant and antioxidante effects by quenching radiation-induced free radical single oxygen: An overview. Cell J 16, 4, 386- 391, (2015)
Downloads
Published
Issue
Section
License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Terms & Condition
Submission -
Author can submit the manuscript through our online submission process or email us at the designated email id in contact details.
The other mode of submission not accepted than online and email.
Before submission please read the submission guidelines.
NN Publication accepts only article submitted in pdf/doc/docx/rtf file format. Another format except given file formats will no be considered .
Author will be responsible for the error mistakes in the submission files. The minor changes can be done without any cost after publication. But for major changes NN Publication may charges you the editing charges.
Publication (Online) -
The online publication is scheduled on last date of every month, but it can be delayed by 24 to 48 hours due to editorial process if huge number of articles comes to publish in single issue.
Automatic notificatation email will be sent to the all users on publication of an issue, so its author’s duty to check their email inbox or SPAM folder to get this notification.
After publication of article author can not withdraw their article.
If editor’s found any issue after publication of article then the NN Publication have the authority to remove the article from online website.
No refund will be provided after online publication of article.
Publication (Print) -
The print copy publication are sent as per the author’s request after 2 weeks of online publication of that issue.
NN Publication will ship the article by India Post and provide the consignment number on dispatch of print copy.
NN Publication follows all the guidelines of delivery provided by IndiaPost and hence not responsible for delay in delivery due to any kind of reasons.
Refund of hard copy will not be provided after dispatch or print of the journal.
NN Publication will be responsible for raise a complain if there is any issue occurs in delivery, but still will not be responsible for providing the refund.
NN Publication will be responsible to resend the print copy only and only if the print copy is lost or print copy is damaged in delivery / or there is delay more than 6 months.
According to India Post the delivery should be completed with in 1-3 weeks after dispatch of articles.
Privacy Policy-
NN Publication uses the email ids of authors and editors and readers for sending editorial or publication notification only, we do not reveal or sell the email ids to any other website or company.
